Hester Larkin

Ms Larkin has a 30-year career spanning pharmaceuticals and nuclear medicine across Europe, Middle East & Africa, including over 12 years' experience in senior roles in the industry. Ms Larkin is currently Managing Director of Hester Larkin Associates Consulting where she consults to diagnostic imaging, pharmaceutical and biotech companies on pre-clinical, clinical, European Medicines Agency (EMA) submission, EU medical advisory boards, EU manufacturing and commercial partnerships. Ms Larkin has held several Director and Trustee positions in the UK and Belgium. She is a Member of risk committee.

Company and Role

Company
Title
Tenure
Since
RAD
Radiopharm Theranostics Limited
  • Non-Executive Director
2yrsFeb 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RAD
Radiopharm Theranostics Limited
08/12/23094,2471,900,002N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RAD
Radiopharm Theranostics Limited
08/12/23
Issued
28,133$0.070$1,969Rights issue
RAD
Radiopharm Theranostics Limited
05/12/22
Issued
1,900,002$0.115$218,500Issue of options
RAD
Radiopharm Theranostics Limited
25/03/22
Buy
66,114$0.260$17,189On-market trade